Ernst Holler

1989–2025 年に発表

127
論文数
23,628
被引用数
84
h 指数
125
i10 指数

被引用数

Ernst Holler の年別被引用数1987 年: 被引用 1 件1990 年: 被引用 2 件1991 年: 被引用 5 件1992 年: 被引用 8 件1993 年: 被引用 11 件1994 年: 被引用 14 件1995 年: 被引用 16 件1996 年: 被引用 24 件1997 年: 被引用 35 件1998 年: 被引用 34 件1999 年: 被引用 36 件2000 年: 被引用 33 件2001 年: 被引用 37 件2002 年: 被引用 42 件2003 年: 被引用 70 件2004 年: 被引用 58 件2005 年: 被引用 53 件2006 年: 被引用 70 件2007 年: 被引用 76 件2008 年: 被引用 74 件2009 年: 被引用 83 件2010 年: 被引用 87 件2011 年: 被引用 138 件2012 年: 被引用 153 件2013 年: 被引用 118 件2014 年: 被引用 134 件2015 年: 被引用 134 件2016 年: 被引用 152 件2017 年: 被引用 160 件2018 年: 被引用 139 件2019 年: 被引用 538 件2020 年: 被引用 798 件2021 年: 被引用 845 件2022 年: 被引用 585 件2023 年: 被引用 448 件2024 年: 被引用 756 件2025 年: 被引用 397 件2026 年: 被引用 10 件1988〜1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,933 件、この内訳の 24.2%ドイツ: 引用元論文 853 件、この内訳の 10.7%フランス: 引用元論文 498 件、この内訳の 6.2%イタリア: 引用元論文 484 件、この内訳の 6.1%中国: 引用元論文 452 件、この内訳の 5.7%イギリス: 引用元論文 433 件、この内訳の 5.4%オランダ: 引用元論文 296 件、この内訳の 3.7%スペイン: 引用元論文 287 件、この内訳の 3.6%カナダ: 引用元論文 263 件、この内訳の 3.3%日本: 引用元論文 224 件、この内訳の 2.8%スイス: 引用元論文 206 件、この内訳の 2.6%オーストラリア: 引用元論文 192 件、この内訳の 2.4%
0%24.2%その他 23.3%

分野

  • Medicine66.5%
  • Biochemistry, Genetics and Molecular Biology18.1%
  • Immunology and Microbiology10.3%
  • Neuroscience1.2%
  • Agricultural and Biological Sciences0.8%
  • Chemistry0.8%
  • その他2.3%

トピック

  • Hematopoietic Stem Cell Transplantation13.8%
  • Immune Cell Function and Interaction5.1%
  • Gut microbiota and health4.9%
  • Acute Myeloid Leukemia Research4.4%
  • T-cell and B-cell Immunology3.9%
  • Acute Lymphoblastic Leukemia research2.6%
  • その他65.3%

共著者

全論文

検索で開く
  1. International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2015 被引用: 960

  2. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nerea Castillo Flores, Ana Alarcón Tomás, Richard J. Lin, Lucrecia Yáñez, Gunjan L. Shah, Christina Cho, Michael Scordo, Ioannis Politikos, Kasumi Hayasaka, Yuta Hasegawa, Boglarka Gyurkocza, Doris M. Ponce, Juliet N. Barker, Miguel‐Angel Perales, Sergio Giralt, Robert R. Jenq, Takanori Teshima, Nelson J. Chao, Ernst Holler, João B. Xavier, Eric G. Pamer, Marcel R.M. van den Brink - New England Journal of Medicine 2020 被引用: 739

  3. Lactose drives Enterococcus expansion to promote graft-versus-host disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anthony D. Sung, Daigo Hashimoto, Christof Scheid, João B. Xavier, Julia A. Messina, Kristi Romero, M. Lew, Amy Bush, Lauren Bohannon, Kasumi Hayasaka, Yuta Hasegawa, Maria J. G. T. Vehreschild, Justin R. Cross, Doris M. Ponce, Miguel‐Angel Perales, Sergio Giralt, Robert R. Jenq, Takanori Teshima, Ernst Holler, Nelson J. Chao, Eric G. Pamer, Jonathan U. Peled, Marcel R.M. van den Brink - Science 2019 被引用: 369

  4. Graft-versus-host disease

    著者: , , , - The Lancet 2009 被引用: 2,444

  5. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Haematology 2020 被引用: 538

  6. Acute graft-versus-host disease

    著者: , , , , - Nature Reviews Disease Primers 2023 被引用: 243

  7. EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment

    著者: , , , , , , , , , , , , , - Bone Marrow Transplantation 2018 被引用: 491

  8. Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host Disease

    著者: , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2014 被引用: 543

  9. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hildegard Greinix, Stefanie Sarantopoulos, Gèrard Socié, Bruce R. Blazar, Joseph Pidala, Carrie L. Kitko, Daniel R. Couriel, Corey Cutler, Kirk R. Schultz, Steven Z. Pavletic, Stephanie J. Lee, Sophie Paczesny - Transplantation and Cellular Therapy 2021 被引用: 143

  10. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2009 被引用: 719

  11. Adjusting microbiome profiles for differences in microbial load by spike-in bacteria

    著者: , , , , , , , - Microbiome 2016 被引用: 286

  12. The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ernst Holler, Miguel‐Angel Perales, Doris M. Ponce, Sean M. Devlin, João B. Xavier, Anthony D. Sung, Jonathan U. Peled, Justin R. Cross, Marcel R.M. van den Brink - Blood 2020 被引用: 165

  13. Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation

    著者: , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2017 被引用: 245

  14. Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation

    著者: , , , , , , - Frontiers in Immunology 2016 被引用: 437

  15. Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Émilie Plantamura, Mohamad Mohty - EClinicalMedicine 2023 被引用: 48

  16. Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2007 被引用: 516

  17. Quantification of Fecal Short Chain Fatty Acids by Liquid Chromatography Tandem Mass Spectrometry—Investigation of Pre-Analytic Stability

    著者: , , , , , , , , , , - Biomolecules 2019 被引用: 111

  18. MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , George Morales, I.M. Torres, Umut Özbek, James L.M. Ferrara, John E. Levine - Blood 2018 被引用: 210

  19. Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dietger Niederwieser, Georg‐Nikolaus Franke, Inken Hilgendorf, Nils Winkelmann, Domenico Russo, Gèrard Socié, Régis Peffault de Latour, Ernst Holler, Daniel Wolff, Bertram Glaß, Jochen Casper, Gerald Wulf, H Menzel, Nadežda Basara, Maria Bieniaszewska, Gernot Stuhler, Mareike Verbeek, Sandra Graß, Anna Paola Iori, Jürgen Finke, Fabio Benedetti, Uwe Pichlmeier, Claudia Hemmelmann, Michael Tribanek, Anja Klein, H. A. Mylius, Joachim Baumgart, Monika Dzierżak‐Mietła, Mirosław Markiewicz - The Lancet Haematology 2019 被引用: 154

  20. Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karin Kleigrewe, Wolfgang Herr, Florian Bassermann, André Gessner, Li Deng, Ernst Holler, Hendrik Poeck - Nature Cancer 2024 被引用: 35

  21. Pathophysiology of GvHD and Other HSCT-Related Major Complications

    著者: , , , , , - Frontiers in Immunology 2017 被引用: 254

  22. Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2009 被引用: 394

  23. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group

    著者: , , , , , , , , , , , , , , , , - Haematologica 2007 被引用: 394

  24. A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study

    著者: , , , , , , , , , , , - The Lancet Haematology 2014 被引用: 306